ANI Pharmaceuticals Reports Third-Quarter 2026 Results
Story updates
11:52:18 AM UTC
SquawkNews
ANI Pharmaceuticals Reports Third Quarter 2026 Financial Results Quarterly net revenues of $290.8 mi
Related stories
ANI Pharmaceuticals raises 2026 adjusted EPS view to $9.37–$9.71
M impact | EARNINGS | Nov 05, 2026, 12:05 PM UTC
ANI Pharmaceuticals Reports Third-Quarter Revenue of $290.8 Million
M impact | EQUITY | Nov 05, 2026, 11:58 AM UTC
Wheels Up Experience Reports Third-Quarter Revenue of $164.8M
M impact | EQUITY | Nov 05, 2026, 11:57 AM UTC
Wheels Up Announces Third-Quarter Results
Wheels Up said its business transformation has reached an inflection point, with Signature fleets delivering the majority of an unspecified measure.
M impact | EQUITY | Nov 05, 2026, 11:57 AM UTC
US Foods Q3 Revenue Misses Estimates; Trims FY Sales View
M impact | EQUITY | Nov 05, 2026, 11:57 AM UTC
LSEG Agrees to Acquire Octus
LSEG agreed on October 22, 2026, to buy Octus.
M impact | EQUITY | Nov 05, 2026, 11:57 AM UTC